Letter by Löwe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".
作者信息
Löwe Axel Lennart, Collet Tinh-Hai, Rodondi Nicolas
机构信息
Institute of Primary Health Care (Berner Institut für Hausarztmedizin), University of Bern, Switzerland (A.L.L., N.R.).
Department of General Internal Medicine, Inselspital, Bern University Hospital, Switzerland (A.L.L., N.R.).
出版信息
Circulation. 2018 May 29;137(22):2415-2416. doi: 10.1161/CIRCULATIONAHA.117.032213.
Abstract
摘要
相似文献
1
Letter by Löwe et al Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".洛维等人就文章《低密度脂蛋白胆固醇水平原发性升高至190mg/dL及以上男性心血管疾病一级预防中的低密度脂蛋白胆固醇降低：西苏格兰冠心病预防研究（WOSCOPS）5年随机试验及20年观察性随访分析》所写的信
Circulation. 2018 May 29;137(22):2415-2416. doi: 10.1161/CIRCULATIONAHA.117.032213.
2
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up.男性原发性低密度脂蛋白胆固醇水平升高至 190mg/dL 或以上的心血管疾病一级预防中降低低密度脂蛋白胆固醇：来自 WOSCOPS（苏格兰西部冠状动脉预防研究）5 年随机试验和 20 年观察随访的分析。
Circulation. 2017 Nov 14;136(20):1878-1891. doi: 10.1161/CIRCULATIONAHA.117.027966. Epub 2017 Sep 6.
3
Letter by Koh Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".Koh 就文章《低密度脂蛋白胆固醇水平原发性升高至190mg/dL及以上男性心血管疾病一级预防的低密度脂蛋白胆固醇降低：来自WOSCOPS（苏格兰西部冠心病预防研究）5年随机试验和20年观察性随访的分析》所写的信
Circulation. 2018 May 29;137(22):2417-2418. doi: 10.1161/CIRCULATIONAHA.117.033136.
4
Response by Vallejo-Vaz et al to Letters Regarding Article, "Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up".瓦列霍 - 瓦斯等人对关于文章《低密度脂蛋白胆固醇水平原发性升高至190mg/dL及以上男性心血管疾病一级预防的低密度脂蛋白胆固醇降低治疗：西苏格兰冠心病预防研究（WOSCOPS）5年随机试验及20年观察性随访分析》的信件的回应
Circulation. 2018 May 29;137(22):2419-2420. doi: 10.1161/CIRCULATIONAHA.118.033781.
5
Closing the Remaining Evidence Gap: Randomized Controlled Trial Data to Support Statin Therapy for Low-Density Lipoprotein ≥190 mg/dL.弥合剩余的证据差距：支持他汀类药物治疗低密度脂蛋白≥190 mg/dL的随机对照试验数据
Circulation. 2017 Nov 14;136(20):1892-1894. doi: 10.1161/CIRCULATIONAHA.117.030989.
6
[Statins in primary prevention of coronary heart disease].[他汀类药物在冠心病一级预防中的应用]
Wien Med Wochenschr. 1999;149(5-6):129-38.
7
8
Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.米泊美生，一种载脂蛋白 B 合成抑制剂，可降低高心血管风险严重高胆固醇血症患者的致动脉粥样硬化脂蛋白：一项随机、双盲、安慰剂对照试验。
J Am Coll Cardiol. 2013 Dec 10;62(23):2178-84. doi: 10.1016/j.jacc.2013.07.081. Epub 2013 Sep 4.
9
Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.他汀类药物一级预防心血管疾病的证据：更新的临床结果与实际实践之间的差距。
Arch Cardiovasc Dis. 2014 Mar;107(3):188-200. doi: 10.1016/j.acvd.2014.01.011. Epub 2014 Mar 7.
10
Individualized Risk Communication and Outreach for Primary Cardiovascular Disease Prevention in Community Health Centers: Randomized Trial.社区卫生中心原发性心血管疾病预防的个性化风险沟通与推广：随机试验
Circ Cardiovasc Qual Outcomes. 2015 Nov;8(6):560-6. doi: 10.1161/CIRCOUTCOMES.115.001723. Epub 2015 Nov 10.
Zotero 插件